These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19505310)

  • 1. In-hospital contact investigation among health care workers after exposure to smear-negative tuberculosis.
    Ringshausen FC; Schlösser S; Nienhaus A; Schablon A; Schultze-Werninghaus G; Rohde G
    J Occup Med Toxicol; 2009 Jun; 4():11. PubMed ID: 19505310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agreement between QuantiFERON®-TB Gold In-Tube and the tuberculin skin test and predictors of positive test results in Warao Amerindian pediatric tuberculosis contacts.
    Verhagen LM; Maes M; Villalba JA; d'Alessandro A; Rodriguez LP; España MF; Hermans PW; de Waard JH
    BMC Infect Dis; 2014 Jul; 14():383. PubMed ID: 25012075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
    Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
    Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
    Matsumoto T; Yamazaki T
    Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers.
    Ringshausen FC; Nienhaus A; Schablon A; Schlösser S; Schultze-Werninghaus G; Rohde G
    BMC Infect Dis; 2010 Jul; 10():220. PubMed ID: 20653946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting.
    Chandrasekaran P; Mave V; Thiruvengadam K; Gupte N; Shivakumar SVBY; Hanna LE; Kulkarni V; Kadam D; Dhanasekaran K; Paradkar M; Thomas B; Kohli R; Dolla C; Bharadwaj R; Sivaramakrishnan GN; Pradhan N; Gupte A; Murali L; Valvi C; Swaminathan S; Gupta A;
    PLoS One; 2018; 13(8):e0199360. PubMed ID: 30067752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis.
    Hamada Y; Gupta RK; Quartagno M; Izzard A; Acuna-Villaorduna C; Altet N; Diel R; Dominguez J; Floyd S; Gupta A; Huerga H; Jones-López EC; Kinikar A; Lange C; van Leth F; Liu Q; Lu W; Lu P; Rueda IL; Martinez L; Mbandi SK; Muñoz L; Padilla ES; Paradkar M; Scriba T; Sester M; Shanaube K; Sharma SK; Sloot R; Sotgiu G; Thiruvengadam K; Vashishtha R; Abubakar I; Rangaka MX
    EClinicalMedicine; 2023 Feb; 56():101815. PubMed ID: 36636295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts.
    Arend SM; Thijsen SF; Leyten EM; Bouwman JJ; Franken WP; Koster BF; Cobelens FG; van Houte AJ; Bossink AW
    Am J Respir Crit Care Med; 2007 Mar; 175(6):618-27. PubMed ID: 17170386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors for latent tuberculosis in polish healthcare workers: the comparison of tuberculin skin test and interferon-gamma release assay (IGRA) performance.
    Szturmowicz M; Broniarek-Samson B; Demkow U
    J Occup Med Toxicol; 2021 Sep; 16(1):38. PubMed ID: 34470622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost analysis of tuberculin skin test and the QuantiFERON-TB Gold In-tube test for tuberculosis screening in a correctional setting in Dallas, Texas, USA.
    Nijhawan AE; Iroh PA; Brown LS; Winetsky D; Porsa E
    BMC Infect Dis; 2016 Oct; 16(1):564. PubMed ID: 27733123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of tuberculin skin test and QuantiFERON-TB Gold In-Tube test in Bacillus Calmette-Guerin-vaccinated children.
    Shah I; Kathwate J; Shetty NS
    Lung India; 2020; 37(1):24-29. PubMed ID: 31898617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
    Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
    Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relating Tuberculosis (TB) Contact Characteristics to QuantiFERON-TB-Gold and Tuberculin Skin Test Results in the Toronto Pediatric TB Clinic.
    Rose W; Read SE; Bitnun A; Rea E; Stephens D; Pongsamart W; Kitai I
    J Pediatric Infect Dis Soc; 2015 Jun; 4(2):96-103. PubMed ID: 26407408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis.
    Pooran A; Booth H; Miller RF; Scott G; Badri M; Huggett JF; Rook G; Zumla A; Dheda K
    BMC Pulm Med; 2010 Feb; 10():7. PubMed ID: 20170555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases.
    Bartalesi F; Vicidomini S; Goletti D; Fiorelli C; Fiori G; Melchiorre D; Tortoli E; Mantella A; Benucci M; Girardi E; Cerinic MM; Bartoloni A
    Eur Respir J; 2009 Mar; 33(3):586-93. PubMed ID: 19047313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia.
    Adetifa IM; Lugos MD; Hammond A; Jeffries D; Donkor S; Adegbola RA; Hill PC
    BMC Infect Dis; 2007 Oct; 7():122. PubMed ID: 17961228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QuantiFERON®-TB Gold In-Tube assay vs. tuberculin skin test in Indonesian children living with a tuberculosis case.
    Rutherford ME; Nataprawira M; Yulita I; Apriani L; Maharani W; van Crevel R; Hill PC; Alisjahbana B
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):496-502. PubMed ID: 22325792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of the Interferon-Gamma Release Assay for Latent Tuberculosis Infection Screening among Indian Health-Care Workers.
    Girish S; Kinikar A; Pardesh G; Shelke S; Basavaraj A; Chandanwale A; Kadam D; Josh S; Dhumal G; Lokhande N; Deluca A; Gupte N; Gupta A; Bollinger RC; Mave V
    Indian J Community Med; 2021; 46(2):281-284. PubMed ID: 34321742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.
    Dorman SE; Belknap R; Graviss EA; Reves R; Schluger N; Weinfurter P; Wang Y; Cronin W; Hirsch-Moverman Y; Teeter LD; Parker M; Garrett DO; Daley CL;
    Am J Respir Crit Care Med; 2014 Jan; 189(1):77-87. PubMed ID: 24299555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.